ANPRX
Price
$34.27
Change
+$0.27 (+0.79%)
Updated
Aug 21 closing price
Net Assets
572.95M
MVCAX
Price
$35.39
Change
+$0.19 (+0.54%)
Updated
Aug 21 closing price
Net Assets
17.65B
Interact to see
Advertisement

ANPRX vs MVCAX

ANPRX vs MVCAX Comparison Chart in %
View a ticker or compare two or three
VS
ANPRX vs. MVCAX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANPRX is a Hold and MVCAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 17.7B vs. ANPRX (573M). ANPRX (1.11) and MVCAX (1.09) have matching dividends . ANPRX was incepted earlier than MVCAX: ANPRX (9 years) vs MVCAX (25 years). MVCAX (0.98) is less costly to investors than ANPRX (0.76). ANPRX is a more actively managed with annual turnover of: 57.00 vs. MVCAX (24.00). ANPRX has a lower initial minimum investment than MVCAX: ANPRX (0) vs MVCAX (1000). ANPRX annual gain was more profitable for investors over the last year : 18.29 vs. MVCAX (13.14). MVCAX return over 5 years is better than : 20.74 vs. ANPRX (-5.43).
ANPRXMVCAXANPRX / MVCAX
Total Expense Ratio0.600.9762%
Annual Report Gross Expense Ratio0.760.9878%
Fund Existence9 years25 years-
Gain YTD19.74117.692112%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets573M17.7B3%
Annual Yield % from dividends1.111.09102%
Returns for 1 year18.2913.14139%
Returns for 3 years29.4629.6899%
Returns for 5 years-5.4320.74-26%
Returns for 10 yearsN/A86.14-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NAGE3.210.06
+1.90%
Niagen Bioscience Inc
GSK52.410.45
+0.87%
GSK plc
OTEX24.670.07
+0.26%
Open Text Corp
FEDU9.80N/A
N/A
Four Seasons Education (Cayman)
CERT8.43-0.30
-3.44%
Certara